Foldax® Announces Positive 1-Year Data on TRIA™ Mitral Valve
Please note that the following pages are exclusively reserved for health care professionals in countries with applicable health authority product registrations. To the extent this site contains information, reference guides and databases intended for use by licensed medical professionals, such materials are not intended to offer professional medical advice. Prior to use, please consult device labeling for prescriptive information and operating instructions.
You are switching to a website for another country and will be subject to the terms and policies therein. Products on that website may or may not be available or approved for your location. Please contact your Foldax representative if you have questions about the availability of products in your location. By continuing, you acknowledge and agree to the terms of this notice.
Limited by Federal (or United States) law to investigational use only.
TRIA™ Mitral Valves are approved for use in India by CDSCO
Uniquely formulated polymer developed specifically for heart valves, “LifePolymer™” material is biocompatible, resists calcification, and eliminates the need for animal-based sourcing.1,2
Robotic automation ensures precision and consistency, reducing manufacturing costs and enabling scalable production to meet growing demand.3
TRIA™ valves are designed to meet the needs of diverse patient groups, including younger individuals and those with conditions like rheumatic heart disease (RHD), enabling broader demographic access.
Explore our groundbreaking innovations through these videos, showcasing how we are addressing global unmet needs and transforming heart valve technology.
Bob, the first patient to receive a TRIA™ heart valve, celebrates his five year anniversary! Hear how Bob’s life has changed since he received the TRIA™ valve.
Joe talks about why he chose the TRIA™ heart valve and how it has helped him get back to doing the things he loves.
